Cargando…

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma

Predictive biomarkers of the response of hepatocellular carcinoma (HCC) to Lenvatinib therapy have not yet been clarified. The aim of this study was to identify clinically significant biomarkers of response to Lenvatinib therapy, to target strategies against HCC. Levels of circulating angiogenic fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuma, Makoto, Uojima, Haruki, Numata, Kazushi, Hidaka, Hisashi, Toyoda, Hidenori, Hiraoka, Atsushi, Tada, Toshifumi, Hirose, Shunji, Atsukawa, Masanori, Itokawa, Norio, Arai, Taeang, Kako, Makoto, Nakazawa, Takahide, Wada, Naohisa, Iwasaki, Shuitirou, Miura, Yuki, Hishiki, Satoshi, Nishigori, Shuhei, Morimoto, Manabu, Hattori, Nobuhiro, Ogushi, Katsuaki, Nozaki, Akito, Fukuda, Hiroyuki, Kagawa, Tatehiro, Michitaka, Kojiro, Kumada, Takashi, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073176/
https://www.ncbi.nlm.nih.gov/pubmed/31991869
http://dx.doi.org/10.3390/cancers12020293